OCM
AGN

Oaktree Capital Management’s Allergan plc AGN Stock Holding History

Oaktree Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-71,000
Closed -$74.2M – 184
2015
Q2 		$74.2M Buy
+71,000
New +$21.2M 0.86% 29

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Oaktree Capital Management's AGN Position: Q3 2015 in Review

Oaktree Capital Management sold out of Allergan plc (AGN) in Q3 2015, closing a stake of 71,000 shares — an estimated $74.2M sold.

Oaktree Capital Management first reported a position in AGN in Q2 2015 and held it in 1 quarter. The position peaked at $74.2M in Q2 2015. 1,056 funds tracked by Wall St. Rank hold AGN as of Q3 2015.

  • Oaktree Capital Management reported no remaining Allergan plc position as of Q3 2015 after selling out during the quarter.
  • Oaktree Capital Management sold 71,000 Allergan plc shares in Q3 2015, an estimated $74.2M.
  • Oaktree Capital Management first reported a position in Allergan plc in Q2 2015 and held it in 1 quarter.
  • Oaktree Capital Management's Allergan plc position peaked at $74.2M in Q2 2015.
  • 1,056 funds tracked by Wall St. Rank held Allergan plc as of Q3 2015.

Based on Oaktree Capital Management's 13F filing for Q3 2015, filed 13 Nov 2015.